We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




IVD Kit detects Infections in Joint Replacements

By LabMedica International staff writers
Posted on 16 Jun 2010
An in vitro diagnostic kit detects the presence or absence of bacterial infections (coagulous-negative Staphylococcus and streptococci) in artificial joint replacements.

Called BJI InoPlex, the kit detects approximately 75 % cent of infections found in joint replacements. More...
It uses several recombinant protein antigens to enable users to carry out key tasks in diagnosing and treating these infections. This includes confirming or eliminating an infection from among bacterial groups that are most commonly found in bone and joint infections (Staphylococcus), assessing the potential for infection by detecting the patient's immunoreaction, and enabling the biological monitoring of antibiotic treatment in patients.

Ingen Biosciences (Chilly-Mazarin, France), a developer and marketer of advanced in vitro diagnostic kits for clinical use, announced that the company will market BJI InoPlex in Europe. The kit consists of a panel of new high-standard antigens developed by the company.

The alternative to Ingen Biosciences' noninvasive serological test is to put patients through a lengthy and costly surgical procedure to open up the knee joint, for example, and search for the infection. BJI InoPlex offers major economic benefits in detecting, treating, and monitoring infection in the joint replacement process.

Through a standard industry technology license, Ingen Biosciences has the rights to sell the kit in Europe. The company plans to sell to other geographic markets in the future. The company also plans to launch a second-generation diagnostics kit in 2011 that will include new antigens to detect other infections in joint replacements.

The Ingen Biosciences Group develops and markets advanced in vitro diagnostic kits for clinical use. Its primary focus is on infectious diseases and immunology, including HLA testing.

Related Links:
Ingen Biosciences



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Urine Analyzer
respons® UDS100
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.